logo
المنزل / القضايا / Korean frontier R&D and biotechnology
أحدث حالة شركة حول Korean frontier R&D and biotechnology
Korean frontier R&D and biotechnology
Published Date: 2026-09-15 10:07:50
Case Detail
R&D and Innovation
Dual-Core R&D System

KMAXS Group operates a dual-core research system connecting market application in China with frontier biotechnology in Korea.

Guangzhou Central Laboratory

Covering approximately 2,000 square meters, the Guangzhou innovation center focuses on:

  • Applied formula development
  • Product efficacy evaluation
  • Market-oriented innovation
  • Stability and safety testing
  • Packaging compatibility
  • Consumer experience and sensory optimization
  • Rapid commercialization of new technologies
Korean Innovation Institute

Covering approximately 1,000 square meters, the Korean research platform focuses on:

  • Frontier skin science
  • Synthetic biotechnology
  • Bioactive peptides
  • Oral and scalp microecology
  • Natural active ingredient extraction and stabilization
  • Microencapsulation and controlled-release technologies
  • Advanced pharmaceutical and cosmetic excipient research
Six Core Research Fields
  1. Skin science and skin health
  2. Synthetic biotechnology
  3. Pharmaceutical and functional excipients
  4. Oral and scalp microecology
  5. Bioactive peptides
  6. Microencapsulation and controlled-release delivery systems